{"id":3738,"date":"2022-11-04T09:32:15","date_gmt":"2022-11-04T01:32:15","guid":{"rendered":"http:\/\/zhonghua.gshlw.com\/?p=3738"},"modified":"2022-11-04T09:32:15","modified_gmt":"2022-11-04T01:32:15","slug":"%e5%a4%a9%e5%a2%83%e7%94%9f%e7%89%a9%e5%b0%86%e4%ba%8e2022%e5%b9%b4%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2%e5%ad%a6%e4%bc%9a%ef%bc%88ash%ef%bc%89%e5%b9%b4%e4%bc%9a%e5%85%ac%e5%b8%83%e4%b8%a4%e9%a1%b9","status":"publish","type":"post","link":"http:\/\/zhonghua.gshlw.com\/zixun\/3738.html","title":{"rendered":"\u5929\u5883\u751f\u7269\u5c06\u4e8e2022\u5e74\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\uff08ASH\uff09\u5e74\u4f1a\u516c\u5e03\u4e24\u9879\u6765\u4f50\u5229\u5355\u6297\u6700\u65b0\u7814\u7a76\u6210\u679c"},"content":{"rendered":"<p>\u7f8e\u56fd\u76d6\u745f\u65af\u5821\u548c\u4e2d\u56fd\u4e0a\u6d772022\u5e7411\u67083\u65e5\u00a0 \u5929\u5883\u751f\u7269\uff08\u201c\u516c\u53f8\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aIMAB\uff09\u662f\u4e00\u5bb6\u4ece\u4e34\u5e8a\u9636\u6bb5\u6b63\u8fc8\u5411\u5546\u4e1a\u5316\u7684\u751f\u7269\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u521b\u65b0\u751f\u7269\u836f\u7684\u9776\u70b9\u751f\u7269\u5b66\u7814\u7a76\u3001\u6297\u4f53\u5de5\u827a\u53ca\u4e2d\u7f8e\u4e34\u5e8a\u5f00\u53d1\u548c\u4ea7\u54c1\u5546\u4e1a\u5316\uff0c\u4e3a\u5168\u7403\u8303\u56f4\u5185\u9700\u6c42\u8feb\u5207\u7684\u764c\u75c7\u6cbb\u7597\u9886\u57df\uff0c\u63d0\u4f9b\u65b0\u578b\u6709\u6548\u7684\u6cbb\u7597\u624b\u6bb5\u3002\u516c\u53f8\u4eca\u5929\u5ba3\u5e03\uff0c\u5c06\u4e8e2022\u5e7412\u670810\u65e5\u81f313\u65e5\u4e8e\u7f8e\u56fd\u65b0\u5965\u5c14\u826f\u4e3e\u529e\u7684\u7b2c64\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\uff08ASH\uff09\u5e74\u4f1a\u671f\u95f4\uff0c\u4ee5\u58c1\u62a5\u5f62\u5f0f\u516c\u5e03\u5176\u521b\u65b0CD47\u6297\u4f53\u6765\u4f50\u5229\u5355\u6297\u7684\u6700\u65b0\u8f6c\u5316\u533b\u5b66\u7814\u7a76\u6570\u636e\u3002<\/p>\n<p>\u5929\u5883\u751f\u7269\u603b\u88c1\u3001\u4ee3\u7406\u9996\u5e2d\u6267\u884c\u5b98\u6731\u79c0\u8f69\u535a\u58eb\u8868\u793a\uff1a\u201c\u516c\u53f8\u76ee\u524d\u6b63\u5728\u5feb\u901f\u63a8\u8fdb\u6765\u4f50\u5229\u5355\u6297\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u5e76\u5168\u65b9\u4f4d\u63a2\u7d22\u5176\u4e34\u5e8a\u5e94\u7528\u6f5c\u529b\u53ca\u521b\u65b0\u836f\u7269\u8054\u7528\u65b9\u6848\u3002\u4eca\u5e74ASH\u5927\u4f1a\u4e0a\uff0c\u6211\u4eec\u5c06\u5206\u4eab\u6765\u4f50\u5229\u5355\u6297\u4e0e\u963f\u624e\u80de\u82f7\u8054\u7528\u6cbb\u7597\u9aa8\u9ad3\u589e\u751f\u5f02\u5e38\u7efc\u5408\u5f812\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u751f\u7269\u6807\u5fd7\u7269\u6570\u636e\u5206\u6790\u7ed3\u679c\uff0c\u4ee5\u53ca\u6765\u4f50\u5229\u5355\u6297\u548c\u9776\u5411CD38\u7684\u83f2\u6cfd\u59a5\u5355\u6297\u8054\u5408\u6cbb\u7597\u9ad8\u5371\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u7814\u7a76\u6570\u636e\u3002\u8fd9\u4e9b\u7814\u7a76\u6210\u679c\u5c06\u4e3a\u6211\u4eec\u66f4\u5feb\u3001\u66f4\u7cbe\u51c6\u5730\u5236\u5b9a\u4e34\u5e8a\u5f00\u53d1\u7b56\u7565\u63d0\u4f9b\u575a\u5b9e\u7684\u7406\u8bba\u4f9d\u636e\u3002\u201d<\/p>\n<p>\u4e24\u7bc7\u6458\u8981\u5df2\u516c\u5e03\u4e8eASH\u5b98\u7f51\uff0c\u8bf7\u70b9\u51fb\u94fe\u63a5\u9605\u8bfb\u5b8c\u6574\u5185\u5bb9\uff1a<\/p>\n<p>\u6807\u9898:<\/p>\n<p>Molecular Biomarker Analyses for Exploring the Therapeutic Mechanism of<br \/>\nLemzoparlimab and Azacitidine (AZA) in Newly Diagnosed Higher Risk Myelodysplastic<br \/>\nSyndrome (HR-MDS)<\/p>\n<p>\u6458\u8981ID\uff1a<\/p>\n<p>3974<\/p>\n<p>\u62a5\u544a\u8005\uff1a<\/p>\n<p>\u4e0a\u6d77\u5e02\u7b2c\u516d\u4eba\u6c11\u533b\u9662 \u5e38\u6625\u5eb7\u6559\u6388<\/p>\n<p>\u62a5\u544a\u4e13\u573a\uff1a<\/p>\n<p>604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms: Poster III<\/p>\n<p>\u62a5\u544a\u5730\u70b9\uff1a<\/p>\n<p>Ernest N. Morial \u4f1a\u8bae\u4e2d\u5fc3\uff0cD\u5927\u5385<\/p>\n<p>\u65e5\u671f\/\u65f6\u95f4\uff1a<\/p>\n<p>\u7f8e\u56fd\u4e1c\u90e8\u65f6\u95f42022\u5e7412\u670812\u65e5\u4e0b\u53486:00-8:00<\/p>\n<p>\u6458\u8981\u6982\u8ff0\uff1a\u6765\u4f50\u5229\u5355\u6297\u548c\u963f\u624e\u80de\u82f7\u8054\u5408\u6cbb\u7597\u53ef\u4ee5\u8bf1\u5bfc\u80bf\u7624\u7ec6\u80de\u7684\u9499\u7f51\u86cb\u767d\u8868\u8fbe\u4e0a\u8c03\uff0c\u5e76\u4e14\u57fa\u7ebf\u671f\u9aa8\u9ad3\u4e2d\u5de8\u566c\u7ec6\u80de\u6570\u91cf\u548cCD8\/Treg\u6bd4\u4f8b\u4e0e\u4e34\u5e8a\u7597\u6548\u5448\u6b63\u76f8\u5173\uff0c\u63d0\u793a\u80bf\u7624\u4fc3\u541e\u4fe1\u53f7\u7684\u6fc0\u6d3b\u548c\u6548\u5e94\u7ec6\u80de\u7684\u6570\u91cf\u5bf9\u4e8e\u8054\u5408\u6cbb\u7597\u7684\u6548\u679c\u5177\u6709\u91cd\u8981\u4f5c\u7528\u3002\u53e6\u5916\uff0c\u4e0eTP53\u91ce\u751f\u578b\u60a3\u8005\u76f8\u6bd4\uff0c\u6211\u4eec\u5728\u643a\u5e26TP53\u7a81\u53d8\u7684\u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u8f83\u597d\u7684\u7597\u6548\uff0c\u8fd9\u7c7b\u60a3\u8005\u9aa8\u9ad3\u4e2d\u7684\u80bf\u7624\u7ec6\u80de\u8868\u8fbe\u66f4\u9ad8\u7684\u9499\u7f51\u86cb\u767d\u6c34\u5e73\uff0c\u5e76\u4e14\u5177\u6709\u66f4\u9ad8\u6bd4\u4f8b\u7684\u514d\u75ab\u7ec6\u80de\u6d78\u6da6\u3002\u6b64\u9879\u7814\u7a76\u7ed3\u679c\u63ed\u793a\u4e86\u6765\u4f50\u5229\u5355\u6297\u548c\u963f\u624e\u80de\u82f7\u8054\u5408\u6cbb\u7597HR-MDS\u9002\u5e94\u75c7\uff0c\u5728\u8c03\u8282\u80bf\u7624\u7ec6\u80de\u53ca\u514d\u75ab\u7ec6\u80de\u5c42\u9762\u7684\u4f5c\u7528\u673a\u5236\u3002<\/p>\n<p>\u6807\u9898:<\/p>\n<p>Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in<br \/>\nRelapsed or Refractory Multiple Myeloma<\/p>\n<p>\u6458\u8981ID\uff1a<\/p>\n<p>4462<\/p>\n<p>\u62a5\u544a\u8005\uff1a<\/p>\n<p>\u5929\u5883\u751f\u7269 \u5f20\u71d5\u59ae\u535a\u58eb<\/p>\n<p>\u62a5\u544a\u4e13\u573a\uff1a<\/p>\n<p>651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Poster III<\/p>\n<p>\u62a5\u544a\u5730\u70b9\uff1a<\/p>\n<p>Ernest N. Morial \u4f1a\u8bae\u4e2d\u5fc3\uff0cD\u5927\u5385<\/p>\n<p>\u65e5\u671f\/\u65f6\u95f4\uff1a<\/p>\n<p>\u7f8e\u56fd\u4e1c\u90e8\u65f6\u95f42022\u5e7412\u670812\u65e5\u4e0b\u53486:00-8:00<\/p>\n<p>\u6458\u8981\u6982\u8ff0\uff1a\u901a\u8fc7\u6b64\u9879\u7814\u7a76\uff0c\u6211\u4eec\u53d1\u73b0\u5728\u590d\u53d1\u96be\u6cbb\u7684\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u4e2d\uff0c\u80bf\u7624\u7ec6\u80de\u9ad8\u8868\u8fbeCD47\u548c\u4f4e\u8868\u8fbeCD38\u4e0e\u75be\u75c5\u7684\u9884\u540e\u4e0d\u826f\u5448\u6b63\u76f8\u5173\uff0c\u5e76\u4e14\u8be5\u73b0\u8c61\u5728\u9ad8\u5371\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u4e2d\u51fa\u73b0\u6bd4\u4f8b\u66f4\u9ad8\u3002\u6570\u636e\u663e\u793a\uff0c\u9ad8\u5371\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7ec6\u80de\u5bf9\u4e8e\u8fbe\u96f7\u59a5\u5c24\u5355\u6297\u6216\u83f2\u6cfd\u59a5\u5355\u6297\u7b49CD38\u6297\u4f53\u5355\u836f\u6cbb\u7597\u4e0d\u654f\u611f\uff0c\u800c\u6765\u4f50\u5229\u5355\u6297\u548c\u83f2\u6cfd\u59a5\u5355\u6297\u8054\u5408\u6cbb\u7597\u53ef\u4ee5\u6709\u6548\u589e\u5f3a\u5bf9\u4e8e\u8fd9\u7c7b\u9aa8\u9ad3\u7624\u7ec6\u80de\u7684\u4f53\u5916\u6297\u4f53\u4f9d\u8d56\u7684\u541e\u566c\u6d3b\u6027\u4ee5\u53ca\u4f53\u5185\u6297\u80bf\u7624\u6548\u679c\u3002\u8be5\u7ed3\u679c\u4e3a\u63a2\u7d22\u6765\u4f50\u5229\u5355\u6297\u548c\u83f2\u6cfd\u59a5\u5355\u6297\u8054\u5408\u6cbb\u7597\u9ad8\u5371\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u63d0\u4f9b\u4e86\u4e34\u5e8a\u524d\u6570\u636e\u652f\u6301\u3002<\/p>\n<p>\u8be6\u7ec6\u7814\u7a76\u6570\u636e\u5c06\u4e8e\u5927\u4f1a\u73b0\u573a\u62a5\u544a\u4e2d\u8fdb\u884c\u5206\u4eab\u3002\u516c\u53f8\u5c06\u572812\u670813\u65e5ASH\u5e74\u4f1a\u7ed3\u675f\u540e\u4e8e\u516c\u53f8\u5b98\u7f51\u4e0a\u7ebf\u4e24\u7bc7\u5b8c\u6574\u58c1\u62a5\uff0c\u656c\u8bf7\u671f\u5f85\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7f8e\u56fd\u76d6\u745f\u65af\u5821\u548c\u4e2d\u56fd\u4e0a\u6d772022\u5e7411\u67083\u65e5\u00a0 \u5929\u5883\u751f\u7269\uff08\u201c\u516c\u53f8\u201d\uff09\uff08\u7eb3\u65af\u8fbe\u514b\u80a1\u7968\u4ee3\u7801\uff1aIMAB\uff09\u662f\u4e00\u5bb6\u4ece\u4e34\u5e8a\u9636\u6bb5\u6b63\u8fc8\u5411\u5546\u4e1a\u5316\u7684\u751f\u7269\u836f\u516c\u53f8\uff0c\u81f4\u529b\u4e8e\u521b\u65b0\u751f\u7269\u836f\u7684\u9776\u70b9\u751f\u7269\u5b66\u7814\u7a76\u3001\u6297\u4f53\u5de5\u827a\u53ca\u4e2d\u7f8e\u4e34\u5e8a\u5f00\u53d1\u548c\u4ea7\u54c1\u5546\u4e1a\u5316\uff0c\u4e3a\u5168\u7403\u8303\u56f4\u5185\u9700\u6c42\u8feb\u5207\u7684\u764c\u75c7\u6cbb\u7597\u9886 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3278,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/posts\/3738"}],"collection":[{"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/comments?post=3738"}],"version-history":[{"count":2,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/posts\/3738\/revisions"}],"predecessor-version":[{"id":3748,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/posts\/3738\/revisions\/3748"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/media\/3278"}],"wp:attachment":[{"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/media?parent=3738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/categories?post=3738"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/zhonghua.gshlw.com\/wp-json\/wp\/v2\/tags?post=3738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}